Streptococcus pneumoniae Coinfection in COVID-19: A Series of Three Cases
Bacterial coinfections are not uncommon with respiratory viral pathogens. These coinfections can add to significant mortality and morbidity. We are currently dealing with the SARS-CoV-2 pandemic, which has affected over 15 million people globally with over half a million deaths. Previous respiratory...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Case Reports in Pulmonology |
| Online Access: | http://dx.doi.org/10.1155/2020/8849068 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832550905347571712 |
|---|---|
| author | Chaitanya Pal Paulina Przydzial Ogechukwu Chika-Nwosuh Shrey Shah Pratik Patel Nikhil Madan |
| author_facet | Chaitanya Pal Paulina Przydzial Ogechukwu Chika-Nwosuh Shrey Shah Pratik Patel Nikhil Madan |
| author_sort | Chaitanya Pal |
| collection | DOAJ |
| description | Bacterial coinfections are not uncommon with respiratory viral pathogens. These coinfections can add to significant mortality and morbidity. We are currently dealing with the SARS-CoV-2 pandemic, which has affected over 15 million people globally with over half a million deaths. Previous respiratory viral pandemics have taught us that bacterial coinfections can lead to higher mortality and morbidity. However, there is limited literature on the current SARS-CoV-2 pandemic and associated coinfections, which reported infection rates varying between 1% and 8% based on various cross-sectional studies. In one meta-analysis of coinfections in COVID-19, rates of Streptococcus pneumoniae coinfections have been negligible when compared to previous influenza pandemics. Current literature does not favor the use of empiric, broad-spectrum antibiotics in confirmed SARS-CoV-2 infections. We present three cases of confirmed SARS-CoV-2 infections complicated by Streptococcus pneumoniae coinfection. These cases demonstrate the importance of concomitant testing for common pathogens despite the need for antimicrobial stewardship. |
| format | Article |
| id | doaj-art-5b41cac8a2c843e0926c7fa3f8f0bc9f |
| institution | Kabale University |
| issn | 2090-6846 2090-6854 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Pulmonology |
| spelling | doaj-art-5b41cac8a2c843e0926c7fa3f8f0bc9f2025-02-03T06:05:29ZengWileyCase Reports in Pulmonology2090-68462090-68542020-01-01202010.1155/2020/88490688849068Streptococcus pneumoniae Coinfection in COVID-19: A Series of Three CasesChaitanya Pal0Paulina Przydzial1Ogechukwu Chika-Nwosuh2Shrey Shah3Pratik Patel4Nikhil Madan5Department of Medicine, Newark Beth Israel Medical Center, New Jersey 07112, USADepartment of Medicine, Newark Beth Israel Medical Center, New Jersey 07112, USADivision of Pulmonary and Critical Care Medicine, Department of Medicine, Newark Beth Israel Medical Center, New Jersey 07112, USADivision of Pulmonary and Critical Care Medicine, Department of Medicine, Newark Beth Israel Medical Center, New Jersey 07112, USADivision of Pulmonary and Critical Care Medicine, Department of Medicine, Newark Beth Israel Medical Center, New Jersey 07112, USADivision of Pulmonary and Critical Care Medicine, Department of Medicine, Newark Beth Israel Medical Center, New Jersey 07112, USABacterial coinfections are not uncommon with respiratory viral pathogens. These coinfections can add to significant mortality and morbidity. We are currently dealing with the SARS-CoV-2 pandemic, which has affected over 15 million people globally with over half a million deaths. Previous respiratory viral pandemics have taught us that bacterial coinfections can lead to higher mortality and morbidity. However, there is limited literature on the current SARS-CoV-2 pandemic and associated coinfections, which reported infection rates varying between 1% and 8% based on various cross-sectional studies. In one meta-analysis of coinfections in COVID-19, rates of Streptococcus pneumoniae coinfections have been negligible when compared to previous influenza pandemics. Current literature does not favor the use of empiric, broad-spectrum antibiotics in confirmed SARS-CoV-2 infections. We present three cases of confirmed SARS-CoV-2 infections complicated by Streptococcus pneumoniae coinfection. These cases demonstrate the importance of concomitant testing for common pathogens despite the need for antimicrobial stewardship.http://dx.doi.org/10.1155/2020/8849068 |
| spellingShingle | Chaitanya Pal Paulina Przydzial Ogechukwu Chika-Nwosuh Shrey Shah Pratik Patel Nikhil Madan Streptococcus pneumoniae Coinfection in COVID-19: A Series of Three Cases Case Reports in Pulmonology |
| title | Streptococcus pneumoniae Coinfection in COVID-19: A Series of Three Cases |
| title_full | Streptococcus pneumoniae Coinfection in COVID-19: A Series of Three Cases |
| title_fullStr | Streptococcus pneumoniae Coinfection in COVID-19: A Series of Three Cases |
| title_full_unstemmed | Streptococcus pneumoniae Coinfection in COVID-19: A Series of Three Cases |
| title_short | Streptococcus pneumoniae Coinfection in COVID-19: A Series of Three Cases |
| title_sort | streptococcus pneumoniae coinfection in covid 19 a series of three cases |
| url | http://dx.doi.org/10.1155/2020/8849068 |
| work_keys_str_mv | AT chaitanyapal streptococcuspneumoniaecoinfectionincovid19aseriesofthreecases AT paulinaprzydzial streptococcuspneumoniaecoinfectionincovid19aseriesofthreecases AT ogechukwuchikanwosuh streptococcuspneumoniaecoinfectionincovid19aseriesofthreecases AT shreyshah streptococcuspneumoniaecoinfectionincovid19aseriesofthreecases AT pratikpatel streptococcuspneumoniaecoinfectionincovid19aseriesofthreecases AT nikhilmadan streptococcuspneumoniaecoinfectionincovid19aseriesofthreecases |